Skip to content
Amerise Biosciences logo

Amerise Biosciences

531681 BSE
Price unavailable

Amerise Biosciences (AMERISE) share price was ₹0.82 at the 28 Oct 2026 close; market capitalisation ₹5.47 Cr; sector Industrial Products. The share price rose 24.2% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue was under ₹0.01 Cr, against ₹0.06 Cr a year earlier and net profit was −₹0.08 Cr, against −₹0.01 Cr a year earlier (compared with Jun 2025). Promoters held 0.00% of Amerise Biosciences in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 44/100 (Weak) as of 28 Oct 2026.

Close 28 Oct 2026 ₹0.82 +0.16 +24.24% 1Y

Key Fundamentals

MicrocapIndustrial ProductsCapital Goods
Market Cap
₹5.47 Cr
EBITDA
₹0.00
Return on Equity
0.3%
Debt to Equity
0
Book Value
₹0.82
EPS (TTM)
−₹0.01
52W High
₹1.03
52W Low
₹0.50

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Industrials › Industrial Products › Plastic Products - Industrial

Supreme Industries
₹3,210.6039.5140,783 Cr6.380.36%15.46%19.93%12,488 Cr1,033 Cr
Astral
₹1,357.0063.3236,456 Cr8.990.29%13.18%18.43%6,836 Cr576 Cr
Garware Hi-Tech Films
₹7,084.0042.4316,458 Cr5.660.17%12.73%16.71%2,461 Cr388 Cr
Kingfa Science & Technology
₹6,858.5041.189,294 Cr6.640.29%13.24%17.92%2,244 Cr225 Cr
Finolex Industries
₹141.4914.268,779 Cr1.411.94%9.64%12.75%4,214 Cr616 Cr
Time Technoplast
₹162.6016.078,027 Cr1.960.91%11.44%15.75%6,455 Cr498 Cr
Prince Pipes & Fittings
₹256.5527.802,836 Cr1.720.40%4.57%6.34%2,640 Cr103 Cr
Amerise Biosciences (this company)
——5 Cr1.000.00%0.30%0.39%0 Cr-0 Cr
Median 8 companies₹1,357.0039.519,037 Cr3.810.32%12.09%16.23%3,427 Cr443 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

44 Weak
Overall score

Data confidence 88/100

Category scores

Quality Poor 28
Returns, margins, earnings quality 22% weight
Valuation Weak 42
Cheap vs sector & own history 24% weight
Growth Poor 10
Sales & profit trajectory 9% weight
Financial Health Average 48
Solvency, leverage, coverage 9% weight
Momentum Strong 84
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company is almost debt free.
  • Stock is trading at 0.97 times its book value

Weaknesses

2
  • Company has low interest coverage ratio.
  • Company has a low return on equity of -0.74% over last 3 years.

Technical Indicators

Oscillators

Neutral

Bearish
1
Neutral
7
Bullish
1

Overall

Bullish

Bearish
4
Neutral
7
Bullish
8

Moving Averages

Bullish

Bearish
3
Neutral
0
Bullish
7

Growth Rate

Revenue Growth
50%

change over 1 year

Net Income Growth
-200% lower than 3Y

change over 1 year

Cash Flow Change
-135%

change over 1 year

EBITDA Margin Change
97.35%

change over 1 year

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0
0
0.04
0
0
0
0.19
0.06
0.07
0.04
0.08
0
Expenses
0.07
0.04
0.06
0.02
0.05
0.03
0.02
0.08
0.07
0.11
0.03
0.02
0.08
Operating Profit
-0.07
-0.04
-0.06
0.02
-0.05
-0.03
-0.02
0.11
-0.01
-0.04
0.01
0.06
-0.08
OPM %
—
—
—
50%
—
—
—
57.89%
-16.67%
-57.14%
25%
75%
—
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
-0.07
-0.04
-0.06
0.02
-0.05
-0.03
-0.02
0.11
-0.01
-0.04
0.01
0.06
-0.08
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Net Profit
-0.07
-0.04
-0.06
0.02
-0.05
-0.03
-0.02
0.11
-0.01
-0.04
0.01
0.06
-0.08
EPS (₹)
-0.01
-0.01
-0.01
0
-0.01
0
0
0.02
0
-0.01
0
0.01
-0.01
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
0
0
0
1.18
0
0
9.58
0.01
0.04
0
0
0.19
Expenses
0.05
0.03
0.94
0.02
1.18
0.15
0.17
9.03
0.13
0.19
0.18
0.24
0.24
Operating Profit
-0.05
-0.03
-0.94
-0.02
0
-0.15
-0.17
0.55
-0.12
-0.15
-0.18
-0.24
-0.05
OPM %
—
—
—
—
0%
—
—
5.74%
-1200%
-375%
5.26%
7.69%
-26.32%
Other Income
0
0
0
0
0
0
-0.17
0
0
0
0.19
0.26
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
-0.05
-0.03
-0.94
-0.02
0
-0.15
-0.34
0.55
-0.12
-0.15
0.01
0.02
-0.05
Tax %
0%
0%
0%
0%
—
0%
0%
0%
0%
0%
0%
0%
—
Net Profit
-0.05
-0.03
-0.94
-0.02
0
-0.15
-0.34
0.55
-0.12
-0.15
0.01
0.02
-0.05
EPS (₹)
-0.01
0
-0.14
0
0
-0.02
-0.05
0.08
-0.02
-0.02
0
0
-0.01
Div. Payout %
0%
0%
0%
0%
—
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
6.61
6.61
6.61
6.61
6.61
6.61
6.61
6.61
6.61
6.61
6.61
6.61
Reserves
-0.05
-0.07
-1.01
-1.03
-1.03
-1.18
-1.52
-0.97
-1.09
-1.23
-1.23
-1.21
Borrowings
0
0
0
0
0
0
0
0.08
0.09
0
0
0
Other Liabilities
0
0
0.04
0.01
0.02
0.6
0.54
6.27
0.04
0.01
3.08
2.03
Total Liabilities
6.56
6.54
5.64
5.59
5.6
6.03
5.63
11.99
5.65
5.39
8.46
7.43
Fixed Assets
0
0
0
0
0
0
0
0
0
0
0
0
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
4.82
5.89
2.34
2.31
0.54
5.37
3.04
4.69
4.57
2.27
2.38
3.77
Other Assets
1.74
0.65
3.3
3.28
5.06
0.66
2.59
7.3
1.08
3.12
6.08
3.66
Total Assets
6.56
6.54
5.64
5.59
5.6
6.03
5.63
11.99
5.65
5.39
8.46
7.43
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.27
1.08
-3.56
-0.04
-1.78
4.89
-0.39
0.06
-0.13
-0.17
3.07
-1.06
Investing
0.32
-1.07
3.55
0.03
1.77
-4.89
0.39
-0.15
0.13
0.27
-3.07
1.63
Financing
-0.59
0
0
0
0
0
0
0.08
0.01
-0.09
0
0
Net Cash Flow
0
0
-0.01
-0.01
-0.01
0.01
-0.01
-0.01
0
0.01
0
0.57
Free Cash Flow
0.27
1.08
-3.56
-0.04
-1.78
4.89
-0.39
0.06
-0.13
-0.17
3.07
-1.06
CFO/OP
-540
-3,600
379
200
—
-3,260
229
11
108
113
-1,706
442
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
—
—
—
1,383
—
—
237
0
0
—
—
Inventory Days
—
—
—
—
0
—
—
0
—
—
—
—
Cash Conversion Cycle
—
—
—
—
1,383
—
—
237
0
0
—
—
Working Capital Days
—
—
—
—
1,376
—
—
-1.91
-1,460
-183
—
—
ROCE %
-0.73%
-0.46%
-15.49%
-0.36%
0%
-2.72%
-6.46%
10.18%
-2.12%
-2.73%
0.19%
0.37%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Amerise Biosciences insights

56 extracted metrics + investor summaries across FY09–FY27.

Shareholding Pattern

Public67.49%Others32.51%As ofSep 2026

Documents

Frequently Asked Questions about Amerise Biosciences

What does Amerise Biosciences Ltd do?
Incorporated in 1984, Amerise Biosciences Ltd specializes in NDA, 505(b)(2), and complex formulations.[1]
Where is Amerise Biosciences Ltd (AMERISE) listed?
Amerise Biosciences Ltd trades under code 531681 on the BSE.
Which sector does Amerise Biosciences Ltd belong to?
Amerise Biosciences Ltd is classified under the Industrial Products sector, in the Plastic Products - Industrial industry.
What is the market capitalisation of Amerise Biosciences Ltd?
Amerise Biosciences Ltd has a market capitalisation of ₹5.47 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Amerise Biosciences Ltd?
Over the last 52 weeks Amerise Biosciences Ltd has traded between ₹0.5 and ₹1.03 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Amerise Biosciences Ltd?
Amerise Biosciences Ltd reported a return on equity of 0.30%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1984, Amerise Biosciences Ltd specializes in NDA, 505(b)(2), and complex formulations.[1]

Website amerisebiosciencesltd.life
Face Value ₹ 1
Shares Outstanding 6,66,66,667

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531681.md for Amerise Biosciences Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Industrial Products stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month